EdgarLookup

AN2 Therapeutics, Inc. — SC 13G Filings

10 SC 13G filings on record

This page lists all SC 13G filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 10 SC 13G documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 3/A 4 4/A 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-8 SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G 0001373604-24-000062 Aug 12, 2024
SC 13G 0001214659-24-011905 Jul 3, 2024
SC 13G SC 13G 0001193125-24-091977 Apr 10, 2024
SC 13G SC 13G 0001193125-24-033944 Feb 13, 2024
SC 13G SC 13G 0001193125-23-193456 Jul 25, 2023
SC 13G SC 13G 0001104659-23-019766 Feb 13, 2023
SC 13G SC 13G 0001193125-23-032801 Feb 10, 2023
SC 13G AN2 THERAPEUTICS, INC. 0001104659-22-044249 Apr 8, 2022
SC 13G AN2 THERAPEUTICS, INC. 0001104659-22-044208 Apr 8, 2022
SC 13G THE SCHEDULE 13G 0000921895-22-001065 Apr 4, 2022